Valsartan Rescues Suppressed Mitochondrial Metabolism during Insulin Resistance in C2C12 Myotubes
Cell Biochemistry and Function · 2024
DOI: 10.1002/cbf.4117 ↗At a glance
Journal article in Cell Biochemistry and Function, 2024. Written by Emily C Wyatt and 6 co-authors. Institution: Department of Health and Human Performance, High Point University, High Point, North Carolina, USA. Major MEDLINE topics: Valsartan, Insulin Resistance, Muscle Fibers, Skeletal, Mitochondria. Cited 1 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Support for this work was provided by the Department of Health and Human Performance within the Congdon School of Health Sciences. Additional support was provi….
Abstract (original language)
Elevated circulating branched‐chain amino acids (BCAA) have been linked with the severity of insulin resistance across numerous populations, implicating heightened BCAA metabolism as a potential therapy for insulin resistance. Recently, the angiotensin II type 1 receptor (AT1R) inhibitor Valsartan (VAL) was identified as a potent inhibitor of branched‐chain alpha‐keto acid dehydrogenase kinase (BCKDK), a negative regulator of BCAA metabolism. This work investigated the effect of VAL on myotube metabolism and insulin sensitivity under both insulin sensitive and insulin resistant conditions. C2C12 myotubes were treated with or without VAL at 8 µM for 24 h, both with and without hyperinsulinemic‐induced insulin resistance. Oxygen consumption and extracellular acidification were used to measure mitochondrial and glycolytic metabolism, respectively. Gene expression was assessed via qRT‐PCR, and insulin sensitivity was assessed via Western blot. Insulin resistance significantly reduced both basal and peak mitochondrial function which were rescued to control levels by concurrent VAL. Changes in mitochondrial function occurred without substantial changes in mitochondrial content or related gene expression. Insulin sensitivity and glycolytic metabolism were unaffected by VAL, as was lipogenic signaling and lipid content. Additionally, both VAL and insulin resistance depressed Bckdha expression. Interestingly, an interaction effect was observed for extracellular isoleucine, valine, and total BCAA (but not leucine), suggesting VAL may alter BCAA utilization in an insulin sensitivity‐dependent manner. Insulin resistance appears to suppress mitochondrial function in a myotube model which can be rescued by VAL. Further research will be required to explore the implications of these findings in more complex models.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Health and Human Performance, High Point University, High Point, North Carolina, USA.
- Department of Chemistry, High Point University, High Point, North Carolina, USA.
Funding
- Support for this work was provided by the Department of Health and Human Performance within the Congdon School of Health Sciences. Additional support was provi…
Cite
APA
Wyatt, E. C., VanDerStad, L. R., Cook, N. E., McGovern, M. R., Zaman, T., Lundin, P. M., & Vaughan, R. A. (2024). Valsartan Rescues Suppressed Mitochondrial Metabolism during Insulin Resistance in C2C12 Myotubes. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.4117
Vancouver
Wyatt EC, VanDerStad LR, Cook NE, McGovern MR, Zaman T, Lundin PM, et al. Valsartan Rescues Suppressed Mitochondrial Metabolism during Insulin Resistance in C2C12 Myotubes. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.4117
BibTeX
@article{Wyatt2024,
author = {Wyatt, Emily C and VanDerStad, Lindsey R and Cook, Norah E and McGovern, Macey R and Zaman, Toheed and Lundin, Pamela M and Vaughan, Roger A},
title = {Valsartan Rescues Suppressed Mitochondrial Metabolism during Insulin Resistance in C2C12 Myotubes},
journal = {Cell Biochemistry and Function},
year = {2024},
doi = {10.1002/cbf.4117}
}
EUVIMED